NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/23/2022
Back to search
Official data from USPTO
CRN CLINICAL RESEARCH NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CRN CLINICAL RESEARCH NETWORK
ST13
US500000085233307Class
42
Filing
85233307
Registration
4203043
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/23/2022
Trademark type
Word
Nice classes
42
Filing date
02/03/2011
Registration date
09/04/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2022
Last transaction
03/23/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/10/2011
First use in commerce
08/10/2011
Drawing code
4
Owner type
16
Owner location
NORTH DARTMOUTH, MA
Examiner
JOHNSON, AISHA
Law office
L10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CRN CLINICAL RESEARCH NETWORK, LLC
CRN/Allergy & Respiratory Network, LLC
Representatives
William S. Wyler Flagel & Papakirk
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Basic and clinical research in the field of respiratory science and medicine; Medical and scientific researchconducting clinical trials; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/23/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/23/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/23/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/15/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/04/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/08/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/08/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2017
E815
TEAS SECTION 8 & 15 RECEIVED
09/11/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/04/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/06/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/21/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/28/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
07/27/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/22/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/21/2012
IUAF
USE AMENDMENT FILED
04/25/2012
EISU
TEAS STATEMENT OF USE RECEIVED
04/25/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/22/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2011
PUBO
PUBLISHED FOR OPPOSITION
09/27/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/22/2011
ALIE
ASSIGNED TO LIE
08/18/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/15/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2011
GNRT
NON-FINAL ACTION E-MAILED
05/05/2011
CNRT
NON-FINAL ACTION WRITTEN
05/05/2011
DOCK
ASSIGNED TO EXAMINER
05/03/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/08/2011
NWAP
NEW APPLICATION ENTERED
02/07/2011
Continuous trademark protection
Get notified about every new filing that threatens CRN CLINICAL RESEARCH NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.